- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abattis Bioceuticals Corp (ATTBF)
Abattis Bioceuticals Corp stock price live, this page displays OTC ATTBF stock exchange data. View the ATTBF premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Abattis Bioceuticals Corp real time stock price chart below.
What Is the Abattis Bioceuticals Corp Stock Price Today?
The Abattis Bioceuticals Corp stock price today is 0.0000010.
What Is the Stock Symbol for Abattis Bioceuticals Corp?
The stock symbol for Abattis Bioceuticals Corp is ""ATTBF.""
What Stock Exchange Does Abattis Bioceuticals Corp Trade On?
Abattis Bioceuticals Corp is listed and trades on the OTC Markets stock exchange.
Is Abattis Bioceuticals Corp a Good Stock to Buy?
Determining whether Abattis Bioceuticals Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATTBF quote. (ISIN: CA00258G1037)
What Is the Abattis Bioceuticals Corp Stock Price Today?
The Abattis Bioceuticals Corp stock price today is 0.0000010.
What Is the Stock Symbol for Abattis Bioceuticals Corp?
The stock symbol for Abattis Bioceuticals Corp is ""ATTBF.""
What Stock Exchange Does Abattis Bioceuticals Corp Trade On?
Abattis Bioceuticals Corp is listed and trades on the OTC Markets stock exchange.
Is Abattis Bioceuticals Corp a Good Stock to Buy?
Determining whether Abattis Bioceuticals Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATTBF quote. (ISIN: CA00258G1037)
OTC Markets
Currency in USD
0.0000010
0.0000000(0.00%)
Closed·
Fair Value
An estimate of a Abattis Bioceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0000010
0.0000010
52 wk Range
0.0000010
0.0001340
ATTBF Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week Low
More Info
Fair Value
An estimate of a Abattis Bioceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00000100.0000010
52 wk Range
0.00000100.0001340
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ATTBF Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Abattis Bioceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell
Abattis Bioceuticals Corp Company Profile
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Compare ATTBF to Peers and Sector
Metrics to compare | ATTBF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATTBFPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −1.2x | −0.5x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | 0.0x | 0.8x | 2.6x | |
Price / LTM Sales | 0.0x | 0.7x | 3.2x | |
Upside (Analyst Target) | 0.0% | 97.1% | 45.4% | |
Fair Value Upside | Unlock | 5.9% | 6.9% | Unlock |
Earnings
Latest Release
Apr 29, 2020
EPS / Forecast
-- / --
Revenue / Forecast
226.27K / --
FAQ
What Stock Exchange Does Abattis Bioceuticals Trade On?
Abattis Bioceuticals is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Abattis Bioceuticals?
The stock symbol for Abattis Bioceuticals is "ATTBF."
What Is the Abattis Bioceuticals Market Cap?
As of today, Abattis Bioceuticals market cap is 476.00.
What Is Abattis Bioceuticals's Earnings Per Share (TTM)?
The Abattis Bioceuticals EPS (TTM) is -0.01.
From a Technical Analysis Perspective, Is ATTBF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Abattis Bioceuticals Stock Split?
Abattis Bioceuticals has split 1 times.
How Many Employees Does Abattis Bioceuticals Have?
Abattis Bioceuticals has 0 employees.
What is the current trading status of Abattis Bioceuticals (ATTBF)?
As of 13 Jul 2025, Abattis Bioceuticals (ATTBF) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.